Drug Type Small molecule drug |
Synonyms GRC-CPD-A |
Target |
Mechanism CB2 agonists(Cannabinoid CB2 receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H21F2N3O |
InChIKeyNTPZXHMTJGOMCJ-WDEREUQCSA-N |
CAS Registry916591-01-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Tedalinab | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory pain | Phase 1 | IN | - | |
Neuralgia | Phase 1 | EU | - | |
Osteoarthritis | Phase 1 | IN | - | |
Pain | Phase 1 | - | - |